Hosted in Boston in collaboration with the British Consulate, this event highlights groundbreaking strategies and partnerships accelerating healthcare advancements. Our team will discuss initiatives focusing on innovative treatment pathways and technological breakthroughs. From AI-driven diagnostics to next-generation therapies, the topics are designed to inspire transformative collaborations. Reach out to schedule a discussion with us and explore how our expertise aligns with your goals in innovation.
Richmond Pharmacology Appoints John Hotti as Chief Technology Officer
April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
